Document is current
Any future updates will be listed below
-
Authors
Zhang, Panpan
Niu, Zuoxing
Guo, Hongqian
Zhang, Miao
Jiang, Shusuan
Cao, Baoshan
He, Chaohong
Hou, Xinfang
Zhang, Jian
Yuan, Jiajia https://orcid.org/0000-0002-9614-6279
Zhu, Yujia
Yu, Yingying
Sun, Caixia
Peng, Peng
Fan, Jean
Gong, Jifang https://orcid.org/0000-0003-3798-7024
Zhou, Jun
Shen, Lin https://orcid.org/0000-0003-1134-2922
-
Funding
Funding for this research was provided by:
Beijing Municipal Science & Technology Commission
- License Information
-
More Information
Article History
Received: 17 November 2025
Accepted: 20 April 2026
First Online: 11 May 2026
Competing interests
: J.F. is employed by TransThera Sciences US, Inc. and has stock and other ownership interests in AstraZeneca. C.S., Y.Z. and Y.Y. are employed by TransThera Sciences (Nanjing), Inc. P.P. is employed by and has patents, royalties and other intellectual property in TransThera Sciences (Nanjing), Inc. All other authors declared no competing interests.
